BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: AlZaim I, Hammoud SH, Al-Koussa H, Ghazi A, Eid AH, El-Yazbi AF. Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases. Front Cardiovasc Med 2020;7:602088. [PMID: 33282920 DOI: 10.3389/fcvm.2020.602088] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Bakkar N, Alzaim I, El-yazbi A. Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease. Clinical Science 2022;136:1631-1651. [DOI: 10.1042/cs20220404] [Reference Citation Analysis]
2 Alzaim I, Eid AH, Abd-elrahman KS, El-yazbi AF. Adipose Tissue Mitochondrial Dysfunction and Cardiometabolic Diseases: On the Search for Novel Molecular Targets. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115337] [Reference Citation Analysis]
3 Budek M, Nuszkiewicz J, Piórkowska A, Czuczejko J, Szewczyk-Golec K. Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms. Biomedicines 2022;10:2660. [PMID: 36289922 DOI: 10.3390/biomedicines10102660] [Reference Citation Analysis]
4 Shaaban HH, Alzaim I, El-Mallah A, Aly RG, El-Yazbi AF, Wahid A. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sci 2022;308:120956. [PMID: 36103959 DOI: 10.1016/j.lfs.2022.120956] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Tarsitano MG, Pandozzi C, Muscogiuri G, Sironi S, Pujia A, Lenzi A, Giannetta E. Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation. Nutrients 2022;14:2926. [PMID: 35889883 DOI: 10.3390/nu14142926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Vázquez-solórzano R, Valdés-miramontes E, Porchas-quijada M, Enciso-ramírez M, Contreras-mata GA, Martínez-moreno AG, Barajas-garcía L, Espinoza-garcía AS, Reyes-castillo Z. Leptin-reactive antibodies are distinctly correlated with body composition parameters and metabolic risk indexes in children and adolescents. Clinical and Experimental Immunology 2022;208:233-244. [DOI: 10.1093/cei/uxab001] [Reference Citation Analysis]
7 Mei R, Qin W, Zheng Y, Wan Z, Liu L. Role of Adipose Tissue Derived Exosomes in Metabolic Disease. Front Endocrinol 2022;13:873865. [DOI: 10.3389/fendo.2022.873865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhang Y, Capanoglu E, Jiao L, Yin L, Liu X, Wang R, Xiao J, Lu B. Coarse cereals modulating chronic low-grade inflammation: review. Crit Rev Food Sci Nutr 2022;:1-22. [PMID: 35503432 DOI: 10.1080/10408398.2022.2070596] [Reference Citation Analysis]
9 Liu Y, Li Y, Cheng B, Feng S, Zhu X, Chen W, Zhang H. Comparison of visceral fat lipolysis adaptation to high-intensity interval training in obesity-prone and obesity-resistant rats. Diabetol Metab Syndr 2022;14:62. [PMID: 35501906 DOI: 10.1186/s13098-022-00834-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Obadia N, Andrade G, Leardini-Tristão M, Albuquerque L, Garcia C, Lima F, Daleprane J, Castro-Faria-Neto HC, Tibiriçá E, Estato V. TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice. J Neuroinflammation 2022;19:104. [PMID: 35488354 DOI: 10.1186/s12974-022-02465-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Fakih W, Zeitoun R, AlZaim I, Eid AH, Kobeissy F, Abd-Elrahman KS, El-Yazbi AF. Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention. Obesity (Silver Spring) 2022;30:982-93. [PMID: 35470973 DOI: 10.1002/oby.23400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Alzaim I, Al-saidi A, Hammoud SH, Darwiche N, Al-dhaheri Y, Eid AH, El-yazbi AF. Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue. Cancers 2022;14:1679. [DOI: 10.3390/cancers14071679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sanoudou D, Hill MA, Belanger MJ, Arao K, Mantzoros CS. Editorial: Obesity, metabolic phenotypes and COVID-19. Metabolism 2022;:155121. [PMID: 35026232 DOI: 10.1016/j.metabol.2021.155121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Dwaib HS, Ajouz G, AlZaim I, Rafeh R, Mroueh A, Mougharbil N, Ragi ME, Refaat M, Obeid O, El-Yazbi AF. Phosphorus Supplementation Mitigates Perivascular Adipose Inflammation-Induced Cardiovascular Consequences in Early Metabolic Impairment. J Am Heart Assoc 2021;10:e023227. [PMID: 34873915 DOI: 10.1161/JAHA.121.023227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zou X, Wang L, Xiao L, Xu Z, Yao T, Shen M, Zeng Y, Zhang L. Deciphering the Irregular Risk of Stroke Increased by Obesity Classes: A Stratified Mendelian Randomization Study. Front Endocrinol (Lausanne) 2021;12:750999. [PMID: 34925231 DOI: 10.3389/fendo.2021.750999] [Reference Citation Analysis]
16 Sitar-Tǎut AV, Cozma A, Fodor A, Coste SC, Orasan OH, Negrean V, Pop D, Sitar-Tǎut DA. New Insights on the Relationship between Leptin, Ghrelin, and Leptin/Ghrelin Ratio Enforced by Body Mass Index in Obesity and Diabetes. Biomedicines 2021;9:1657. [PMID: 34829886 DOI: 10.3390/biomedicines9111657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
17 Hammoud SH, AlZaim I, Al-Dhaheri Y, Eid AH, El-Yazbi AF. Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases. Front Endocrinol (Lausanne) 2021;12:707126. [PMID: 34408726 DOI: 10.3389/fendo.2021.707126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Calcaterra V, Verduci E, Schneider L, Cena H, De Silvestri A, Vizzuso S, Vinci F, Mameli C, Zuccotti G. Sex-Specific Differences in the Relationship between Insulin Resistance and Adiposity Indexes in Children and Adolescents with Obesity. Children (Basel) 2021;8:449. [PMID: 34073195 DOI: 10.3390/children8060449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Alaaeddine RA, AlZaim I, Hammoud SH, Arakji A, Eid AH, Abd-Elrahman KS, El-Yazbi AF. The pleiotropic effects of antithrombotic drugs in the metabolic-cardiovascular-neurodegenerative disease continuum: impact beyond reduced clotting. Clin Sci (Lond) 2021;135:1015-51. [PMID: 33881143 DOI: 10.1042/CS20201445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Muzurović EM, Vujošević S, Mikhailidis DP. Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes? J Cardiovasc Pharmacol Ther 2021;26:415-36. [PMID: 33844605 DOI: 10.1177/10742484211006997] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
21 Dwaib HS, AlZaim I, Eid AH, Obeid O, El-Yazbi AF. Modulatory Effect of Intermittent Fasting on Adipose Tissue Inflammation: Amelioration of Cardiovascular Dysfunction in Early Metabolic Impairment. Front Pharmacol 2021;12:626313. [PMID: 33897419 DOI: 10.3389/fphar.2021.626313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
22 Shi H, Kim HW, Weintraub NL. Macrophage immunometabolism in perivascular adipose tissue. Arterioscler Thromb Vasc Biol 2021;41:731-3. [PMID: 33746500 DOI: 10.1161/atvbaha.120.315779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Grigoraș A, Balan RA, Căruntu ID, Giușcă SE, Lozneanu L, Avadanei RE, Rusu A, Riscanu LA, Amalinei C. Perirenal Adipose Tissue-Current Knowledge and Future Opportunities. J Clin Med 2021;10:1291. [PMID: 33800984 DOI: 10.3390/jcm10061291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
24 Kuper CF, Pieters RHH, van Bilsen JHM. Nanomaterials and the Serosal Immune System in the Thoracic and Peritoneal Cavities. Int J Mol Sci 2021;22:2610. [PMID: 33807632 DOI: 10.3390/ijms22052610] [Reference Citation Analysis]
25 Dakroub A, Nasser SA, Kobeissy F, Yassine HM, Orekhov A, Sharifi-Rad J, Iratni R, El-Yazbi AF, Eid AH. Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases. J Cell Physiol 2021;236:6282-96. [PMID: 33634486 DOI: 10.1002/jcp.30345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
26 Bakkar NZ, Dwaib HS, Fares S, Eid AH, Al-Dhaheri Y, El-Yazbi AF. Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders. Int J Mol Sci. 2020;21. [PMID: 33260799 DOI: 10.3390/ijms21239005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]